Clinical Trial Update: Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

View source ↗

Summary

This clinical trial update reports the clinical effectiveness and impact on health-related quality of life after 16 weeks of adalimumab therapy in Peruvian pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Moderate to Severe Psoriasis | Status: TERMINATED | Results posted: 2014-08-25